(Q28361945)

2

0 references

A Grottola

3

0 references

P Buttafoco

4

0 references

M G Buono

5

0 references

F Giannini

6

0 references

M Manno

7

0 references

H Bertani

8

0 references

A Dugani

9

0 references

F Manenti

British Journal of Cancer

10

0 references

language of work or name

English

0 references

publication date

6 April 2001

0 references

published in

0 references

volume

84

0 references

page(s)

881-5

0 references

issue

7

0 references

cites work

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363845

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363845

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363845

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363845

Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363845

Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection

27 November 2018

1 reference

12 December 2020

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

1 reference

12 December 2020

A phase II trial of tamoxifen in hepatocellular carcinoma

1 reference

12 December 2020

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

1 reference

12 December 2020

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen

1 reference

12 December 2020

Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma

1 reference

12 December 2020

Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma

1 reference

12 December 2020

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

12 December 2020

Variant liver estrogen and response to tamoxifen

1 reference

12 December 2020

Type of estrogen receptor determines response to antiestrogen therapy

1 reference

12 December 2020